Raised $14.5M equity financing led by Cordis and Ajax Health

Press Release: Cordis-X Makes Strategic Investment in Adient Medical, Developer of First Fully Absorbable Inferior Vena Cava (IVC) Filter

Obtained Investigative Device Exemption (IDE) approval from FDA to conduct US pivotal study on absorbable filter

Raised $2.2M equity financing led by Becton Dickinson

Development of next generation absorbable filter with 12F profile

1^st issued US patent on delivery system for fully absorbable vascular filter

1^st issued US patent on fully absorbable vascular filter (US: 10383718)

1^st deployment of absorbable vascular filter in human (Elizondo, Eggers, et. al., J. Vasc. Interv. Radiol. 2020;31)

Moved into new headquarters with ISO Class 7 clean room

1^st issued patent on fully absorbable vascular filter (China: ZL201280010783.0)

$3.0M award NIH National Heart Lung & Blood Institute

1^st randomized controlled animal study of absorbable filter (Eggers, Rouselle, et. al. J. Vasc. Interv. Radiol. 2019;30)

1^st place Medtech Innovator award at Wilson Sonsini annual conference

2^nd place Medtech Innovator award at Advamed annual conference

1^st place Medical World Americas annual conference

Texas Medical Center TMCx accelerator inaugural company

$1.5M award NIH National Heart Lung & Blood Institute

Michael DeBakey award for the US life science company with highest potential

Rice Alliance top ten award at annual conference

1^st deployment of absorbable vascular filter in animal (Eggers, Huang. et. al. J Vasc. Surg. 2015;3)

MEST (Medicine, Energy, Space and Technology) award at Rice University annual conference

1^st publication on absorbable vascular filter (Eggers, Reitman. J. Vasc. Interv. Radiol. 2012;23)

1^st place American Medical Association research award (surgery & bioengineering)

1^st patent filed on fully absorbable vascular filter